Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta-Analysis
GastroenterologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Journal of gastroenterology and hepatology
- Publicado em
- 19 mai 2025
- Citações
- 8
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Comparison of Carvedilol to Propranolol in Reduction of Hepatic Venous Pressure Gradient in Liver Cirrhosis: A Meta-Analysis
Amey Joshi, Hafsa Arshad Azam Raja, Poulami Roy, Fakhar Latif, Rahul George Reji, Novonil Deb, Ryan K Mui, Ahmed Shady
Descritores MeSH
- Portal Pressure
- Adrenergic beta-Antagonists
- Carbazoles
- Hepatic Veins
- Hypertension, Portal
- Liver Cirrhosis
- Propanolamines
- Propranolol
- Vascular Resistance
- Treatment Outcome
Veja também
Estudos relacionados
- Hemodynamic effects of carvedilol plus simvastatin in cirrhosis with severe portal hypertension and suboptimal response to β-blockers: A double-blind, placebo-controlled, randomized trial
- Comparison of Carvedilol and Propranolol in Reducing the Portal Vein Pressure: A Systematic Review and Meta-analysis
- Carvedilol to prevent hepatic decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by new non-invasive model (CHESS2306)
- Carvedilol and traditional nonselective beta blockers for the secondary prophylaxis of variceal hemorrhage and portal hypertension related complications among patients with decompensated cirrhosis: a systematic review and network meta-analysis